Nektar Therapeutics (NKTR) — Free Cash Flow Generation Index
Nektar Therapeutics (NKTR) has a Free Cash Flow Generation Index of 1.00x as of June 2018. Free cash flow of $956.90 Million represents 1% of operating cash flow ($959.64 Million). Read Nektar Therapeutics (NKTR) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Nektar Therapeutics Free Cash Flow Generation Index (1997–2018)
Historical FCF Generation Index trend for Nektar Therapeutics across 4 annual periods. Explore NKTR capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Nektar Therapeutics (1997–2018)
Year-by-year Free Cash Flow Generation Index for Nektar Therapeutics. For the full company profile including market capitalisation, see Nektar Therapeutics market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.98x | $703.98 Million | $718.21 Million | $14.24 Million | ▲ +104.6% |
| 2009 | 0.48x | $19.04 Million | $39.74 Million | $20.70 Million | ▼ -38.3% |
| 2007 | 0.78x | $113.51 Million | $146.30 Million | $32.80 Million | ▲ +131.5% |
| 1997 | -2.47x | $-12.28 Million | $4.98 Million | $17.26 Million | — |